Kymera Therapeutics Inc. (KYMR) at a glance

Kymera Therapeutics Inc. (KYMR) is a mid-cap Healthcare company. It trades at $114.96, with a 0% profit margin and revenue growth of 55.5%. It does not pay a dividend. Vestovix scores it 54/100 overall. Its strongest dimension is Growth (94/100) and its weakest is Safety (12/100). It carries above-market volatility, so expect larger swings.

Price

$114.96

Market cap

$7.09B

P/E ratio

n/a

Dividend yield

None

Beta

2.03

52-week range

$39.84 to $130.05